vadimezan has been researched along with pentetic acid in 1 studies
| Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (pentetic acid) | Trials (pentetic acid) | Recent Studies (post-2010) (pentetic acid) |
|---|---|---|---|---|---|
| 272 | 16 | 101 | 7,774 | 301 | 587 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellnier, DA; Cheney, RT; Maiery, PG; Mazurchuk, R; Seshadri, M; Spernyak, JA | 1 |
1 other study(ies) available for vadimezan and pentetic acid
| Article | Year |
|---|---|
Visualizing the acute effects of vascular-targeted therapy in vivo using intravital microscopy and magnetic resonance imaging: correlation with endothelial apoptosis, cytokine induction, and treatment outcome.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Capillary Permeability; Colonic Neoplasms; Contrast Media; Drug Delivery Systems; Drug Screening Assays, Antitumor; Endothelium, Vascular; Female; Hemorrhage; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Microscopy; Neoplasm Proteins; Neoplasm Transplantation; Pentetic Acid; Polylysine; RNA, Messenger; RNA, Neoplasm; Skin Window Technique; Transplantation, Heterotopic; Transplantation, Isogeneic; Tumor Necrosis Factor-alpha; Xanthones | 2007 |